Atlas Trials

Efficacy and Safety of a Third-Course of Neoadjuvant Immunochemotherapy Combined With SBRT in Locally Advanced Head and Neck Squamous Cell Carcinoma Patients With Stable Disease After Two Treatment Courses: A Single-Arm Exploratory Study

Clinical trial NCT06722495 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06722495
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
SBRTNeoadjuvant ImmunochemotherapyLA HNSCC
Start date
2024-12-24
Primary completion
2026-09-26
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.